Vice President of Program & Alliance Management
Michele Keough is Vice President, Program and Alliance Management at Aura Biosciences. Michele has more than 15 years of experience leading product development activities from discovery and pre-clinical stages through clinical development, regulatory approval and commercial launch. Prior to joining Aura, Michele was Head of R&D Operations at Moderna Therapeutics. Prior to that, she spent more than 15 years in positions of increasing responsibility at Genzyme Corporation (now Sanofi), most recently as Senior Director and Project Leader in the Company’s Rare Disease Business Unit, overseeing program and alliance management activities in a variety of therapeutic areas including cardiovascular, immunology, oncology and pulmonology.
Michele holds an MBA from Duke University, an MS in Microbiology and Immunology from Hahnemann University and a BS from the University of Delaware.